¥1,128.00
1.57%
Tokyo, Fri, Sep 18 2026.
ISIN
JP3247090008
Symbol
4569

Kyorin Pharmaceutical Co.,ltd. Stock price

¥1,128.00
-6.00 0.53% 1M
-526.00 31.80% 6M
-409.00 26.61% YTD
-402.00 26.27% 1Y
-697.23 38.20% 3Y
-754.05 40.07% 5Y
-1,049.11 48.19% 10Y
-208.77 15.62% 20Y
Tokyo, Closing price Fri, Sep 18 2026
-18.00 1.57%
ISIN
JP3247090008
Symbol
4569
Industry

Is Kyorin Pharmaceutical Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
¥59.4b
Enterprise Value
¥65.7b
Net debt
¥6.3b
Cash
¥17.0b
Shares outstanding
57.5m
Valuation (TTM | estimate)
P/E
29.8
P/S
0.5 | 0.5
EV/Sales
0.5 | 0.5
EV/FCF
-
P/B
0.4
Dividends
DPS
¥25.00
Yield 1Y | 5Y
2.2% | 2.9%
Growth 1Y | 5Y
-56.1% | -13.6%
Payout 1Y | 3Y
95.0% | 53.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥125.7b | ¥124.4b
EBITDA
¥2.2b
EBIT
¥2.2b
Net Income
¥2.2b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-4.7% | -1.5%
EBITDA
-84.3%
EBIT
-84.4%
Net Income
-78.9%
Free Cash Flow
-
Margin
Gross
40.2%
EBITDA
1.7%
EBIT
1.7%
Net
1.7%
Free Cash Flow
-
Financial Health
Equity Ratio
72.9%
Return on Equity
2.4%
ROCE
1.3%
ROIC
1.1%
Debt/Equity
0.2
More
EPS
¥37.8
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
¥63.2m

Kyorin Pharmaceutical Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Kyorin Pharmaceutical Co.,ltd. forecast:

3x Hold
38%
5x Sell
63%

Analyst Opinions

8 Analysts have issued a Kyorin Pharmaceutical Co.,ltd. forecast:

Hold
38%
Sell
63%

Financial data from Kyorin Pharmaceutical Co.,ltd.

Jun '26
+/-
%
125,682 125,682
5% 5%
100%
- Direct Costs 75,141 75,141
5% 5%
60%
50,541 50,541
16% 16%
40%
- Selling and Administrative Expenses 48,376 48,376
4% 4%
38%
- Research and Development Expense - -
-
-
2,163 2,163
84% 84%
2%
- Depreciation and Amortization 10 10
44% 44%
0%
EBIT (Operating Income) EBIT 2,153 2,153
84% 84%
2%
Net Profit 2,172 2,172
79% 79%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyorin Pharmaceutical Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,998 full-time employees. The company went IPO on 2006-03-10. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The firm also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.

Head office Japan
CEO Mr. Ogihara
Employees 1,998
Website www.kyorin-pharm.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today